<DOC>
	<DOCNO>NCT00002356</DOCNO>
	<brief_summary>To evaluate efficacy safety ISIS 2922 AIDS patient Cytomegalovirus ( CMV ) retinitis unresponsive intolerant ganciclovir and/or foscarnet otherwise ineligible ISIS Pharmaceuticals ' controlled trial OR fail ISIS 2922 therapy another control clinical trial . PER 2/8/96 AMENDMENT : Patients must rollover another ISIS 2922 control trial .</brief_summary>
	<brief_title>The Safety Effectiveness ISIS 2922 Patients With AIDS Who Have Cytomegalovirus ( CMV ) Eyes</brief_title>
	<detailed_description>Patients receive intravitreal injection ISIS 2922 dose either 150 300 mcg , depend CMV retinitis location extent retinal involvement . There 3-week Induction period follow least 18 week Maintenance . Induction give day 1 , 8 , 15 , Maintenance dose give every 14 day , begin day 29 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Fomivirsen</mesh_term>
	<criteria>Inclusion Criteria Patients must : AIDS . CMV retinitis one eye previously treat presently uncontrolled . Intolerance resistance therapy . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Eligibility participate control clinical trial ISIS 2922 . External ocular infection eye treat . Other herpetic infection retina , toxoplasma retinochoroiditis , diseases fundus eye treat . Ocular condition would obstruct visualization posterior ocular structure eye treat . Retinal detachment eye treat . Known suspected allergy phosphorothioate oligonucleotides . Silicone oil eye treat . Syphilis . Clinical evidence retinal pigment epithelial stippling . Pseudoretinitis pigmentosa . Concurrent Medication : Excluded : Foscarnet . Mellaril , Stelazine , Thorazine , Clofazimine . Ethambutol / fluconazole combination . Other investigational drug CMV retinitis . Patients follow prior condition exclude : History surgery correct retinal detachment eye treat . History ganciclovir implant treatment CMV retinitis . History intolerance ISIS 2922 . History syphilis . Required : Prior CMV retinitis therapy ganciclovir , foscarnet , ISIS 2922 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1998</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Cytomegalovirus Retinitis</keyword>
</DOC>